Ellis P - Search Results

1

Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial.

Tutt A, Tovey H, Cheang MCU, Kernaghan S, Kilburn L, Gazinska P, Owen J, Abraham J, Barrett S, Barrett-Lee P, Brown R, Chan S, Dowsett M, Flanagan JM, Fox L, Grigoriadis A, Gutin A, Harper-Wynne C, Hatton MQ, Hoadley KA, Parikh J, Parker P, Perou CM, Roylance R, Shah V, Shaw A, Smith IE, Timms KM, Wardley AM, Wilson G, Gillett C, Lanchbury JS, Ashworth A, Rahman N, Harries M, Ellis P, Pinder SE, Bliss JM. Tutt A, et al. Among authors: ellis p. Nat Med. 2018 May;24(5):628-637. doi: 10.1038/s41591-018-0009-7. Epub 2018 Apr 30. Nat Med. 2018. PMID: 29713086 Free PMC article. Clinical Trial.

2

Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer.

Ellis PA, Smith IE, Hardy JR, Nicolson MC, Talbot DC, Ashley SE, Priest K. Ellis PA, et al. Br J Cancer. 1995 Feb;71(2):366-70. doi: 10.1038/bjc.1995.74. Br J Cancer. 1995. PMID: 7530988 Free PMC article. Clinical Trial.

3

A pilot study of mitomycin, cisplatin and continuous infusion 5-fluorouracil (MCF) in advanced non-small-cell lung cancer.

Ellis PA, Talbot DC, Nicolson MC, Priest K, Ashley S, Smith IE. Ellis PA, et al. Br J Cancer. 1995 Jun;71(6):1315-8. doi: 10.1038/bjc.1995.255. Br J Cancer. 1995. PMID: 7779730 Free PMC article. Clinical Trial.

4

Dose intensification of carboplatin and etoposide as first-line combination chemotherapy in small cell lung cancer.

Ellis PA, Talbot DC, Priest K, Jones AL, Smith IE. Ellis PA, et al. Eur J Cancer. 1995 Oct;31A(11):1888-9. doi: 10.1016/0959-8049(95)00396-z. Eur J Cancer. 1995. PMID: 8541123 Clinical Trial. No abstract available.

5

Comparison of MIB-1 proliferation index with S-phase fraction in human breast carcinomas.

Ellis PA, Makris A, Burton SA, Titley J, Ormerod MG, Salter J, Powles TJ, Smith IE, Dowsett M. Ellis PA, et al. Br J Cancer. 1996 Mar;73(5):640-3. doi: 10.1038/bjc.1996.111. Br J Cancer. 1996. PMID: 8605100 Free PMC article.

6

Oncogene products and other diagnostic markers in human breast cancer patients. Treatment effects and their significance.

Dowsett M, Makris A, Ellis P, Johnston SR, Salter J, Detre S, Humphries S, Saccani-Jotti G, Powles TJ, Smith IE. Dowsett M, et al. Among authors: ellis p. Ann N Y Acad Sci. 1996 Apr 30;784:403-11. doi: 10.1111/j.1749-6632.1996.tb16254.x. Ann N Y Acad Sci. 1996. PMID: 8651589 Review. No abstract available.

7

Apoptosis--its role in tumour growth and therapy.

Ellis PA, Smith IE, Dowsett M. Ellis PA, et al. Cytopathology. 1996 Jun;7(3):201-3. doi: 10.1046/j.1365-2303.1996.39682396.x. Cytopathology. 1996. PMID: 8782992 Review. No abstract available.

8

Haemolytic uraemic syndrome in a patient with lung cancer: further evidence for a toxic interaction between mitomycin-C and tamoxifen.

Ellis PA, Luckitt J, Treleaven J, Smith IE. Ellis PA, et al. Clin Oncol (R Coll Radiol). 1996;8(6):402-3. doi: 10.1016/s0936-6555(96)80093-8. Clin Oncol (R Coll Radiol). 1996. PMID: 8973862 No abstract available.

9

Preoperative chemotherapy induces apoptosis in early breast cancer.

Ellis PA, Smith IE, McCarthy K, Detre S, Salter J, Dowsett M. Ellis PA, et al. Lancet. 1997 Mar 22;349(9055):849. doi: 10.1016/s0140-6736(05)61752-7. Lancet. 1997. PMID: 9121265 Clinical Trial. No abstract available.

10

Primary chemotherapy for early breast cancer.

Ellis PA, Smith IE. Ellis PA, et al. Cancer Treat Rev. 1996 Nov;22(6):437-50. doi: 10.1016/s0305-7372(96)90025-0. Cancer Treat Rev. 1996. PMID: 9134004 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,346 results

Search Page